Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tango Therapeutics, Inc.
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
June 9, 2026
Tango Therapeutics Announces Proposed $500 Million Public Offering
June 8, 2026
Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer
June 8, 2026
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026